New clinical trial regulation provides positive outlook for EU

In a recent article on Outsourcing Pharma, Dan Stanton discusses the new EU clinical trial regulation and it’s intention to simplify the approval process in hopes of making the EU more accessible and desirable for clinical research. The new regulation will take action...

Setback for EMA’s vision of transparency

Raps.org journalist, Alexander Gaffney reported that an EU court has surprisingly issued an interim order that the European Medicines Agency (EMA) should stop publishing any more information or documents until a final order has been passed regarding public...

European summit examines the reuse of health data

Recently, the International Journal of Medical Informatics published a white paper on the proceedings of the 2012 European Summit on Trustworthy Reuse of Health Data. The meeting, which convened in Brussels, Belgium in May, brought together delegates from government,...